What is Required for 21 CFR Part 111 Compliance?

21 CFR Part 111 is the FDA’s current good manufacturing practice rule for dietary supplements. It applies to companies that manufacture, package, label, or hold dietary supplements for the U.S. market, including foreign companies whose products are offered for import into the United States.

The practical goal of Part 111 is also clear. FDA says the rule requires companies to follow cGMPs to ensure the quality of the dietary supplement and to ensure that the supplement is packaged and labeled as specified in the master manufacturing record.

So what does compliance actually require? The short answer is this: Part 111 is not one rule. It is a working system. It covers people, buildings, equipment, specifications, production controls, quality control, packaging, labeling, complaints, and records. That is why GMP Certification is best understood as a systems issue, not just a checklist exercise.

Start with the core idea: quality must be built into the system

A company is not compliant because it tests a finished product at the end. Part 111 expects quality to be built into the process from the start.

That means the company needs:

• Qualified personnel
• Written procedures
• Defined specifications
• Controlled production steps
• Quality control review
• Proper packaging and labeling controls
• Records that show what happened, not what was supposed to happen

This is why Part 111 is best understood as an operating framework. It is about whether the system is controlled, documented, and repeatable.

1. Qualified personnel and defined responsibilities

CFR Part 111 requires companies to identify who is responsible for quality control operations, and those individuals must have distinct quality control responsibilities. Training must be documented.

In practical terms, a company should be able to answer:

• Who approves raw materials?
• Who reviews batch records?
• Who can release or reject the product?
• Who investigates deviations?
• How is training documented?

If those responsibilities are unclear, compliance usually breaks down later.

2. Physical plant, grounds, and equipment controls

Part 111 also expects the facility itself to support supplement quality. That includes plant and grounds design, sanitation, pest control, plumbing, lighting, ventilation, and equipment that is appropriate for its intended use. Equipment must be designed and maintained to prevent contamination of components or supplements. Instruments and controls used in manufacturing or testing must be calibrated.

This is where some companies underestimate the rule. They focus on paperwork but overlook practical risks such as poor material flow, unclear equipment status, weak maintenance records, or unvalidated clean-outs.

3. Specifications are one of the biggest compliance pillars

The FDA’s compliance guide states that companies must establish specifications for components, in-process controls, finished supplements, packaging, and labels, where applicable. Those specifications are used to determine whether materials and products meet the required identity, purity, strength, composition, and limits on contamination.

This is one of the most important parts of the rule. A company cannot show control if it has not first defined what “acceptable” means.

In practice, that usually includes:

• component identity specifications
• finished product specifications
• microbial or contaminant limits where relevant
• packaging and label specifications
• in-process specifications such as weight variation or blend uniformity

4. Master manufacturing records and batch production records

This is where Part 111 becomes very operational. A company must prepare and follow a master manufacturing record for each unique formulation and batch size. It must also create a batch production record each time the product is made. The master record describes how the supplement is supposed to be produced. The batch record shows what actually happened.

That includes information such as:

• the identity and weight or measure of each component
• equipment and processing instructions
• packaging and labeling instructions
• unique batch identifiers
• actual yields and reconciliation
• documentation of each significant step

This distinction matters. A strong SOP library is helpful, but Part 111 compliance depends heavily on whether actual production records are complete, reviewed, and accurate.

5. Quality control cannot be nominal

Quality control under Part 111 is not a passive function.

FDA says companies must implement quality control in manufacturing, packaging, labeling, and holding. Quality control personnel must approve or reject components, packaging, labels, in-process materials, finished supplements, reprocessing decisions, and investigations where required.

This means QC needs authority, not just presence. If quality staff cannot hold product, reject materials, or require corrections, the system is weak, even if the org chart looks complete.

6. Packaging and labeling controls are part of cGMP

Part 111 does not stop at making the product. It also covers how the product is packaged and labeled.

That includes controls to ensure the correct label is used, to manage label issuance and reconciliation, and to prevent mix-ups. The FDA’s compliance guide makes it explicit that the rule is designed to ensure that the supplement is packaged and labeled as specified in the master manufacturing record.

This is also why broader systems reviews are often useful. If your company manages multiple schemes, how integrated audits work is relevant because overlapping controls around traceability, labeling, sanitation, and documentation can often be reviewed more efficiently together.

7. Holding, distribution, returns, and complaints also matter

Part 111 also reaches beyond the production room.

The rule includes requirements for holding and distributing operations, returned dietary supplements, product complaints, and records. These areas matter because compliance does not end when the batch is released. companies must still control storage, evaluate complaints, and document how returned products are handled.

A firm should be able to show:

• How finished goods are stored
• How distribution records are maintained
• How complaints are evaluated
• How returned goods are handled
• How investigations are documented

8. Records are what make compliance real

Written procedures are required in many areas. Training records must be kept. Specifications, QC decisions, calibration records, sanitation records, master records, batch records, complaint files, and material review decisions all need to be documented and retained in accordance with the rule.

This is why documentation quality is often the real dividing line between a company that talks about compliance and a company that can demonstrate it.

If your team is trying to understand the broader business value of stronger systems, GMP Certification is a useful next step. And if you already know your gap areas, the simplest next move may be to obtain a quote for an audit or gap assessment.

A practical way to judge Part 111 readiness

Before thinking about certification or audit readiness, ask:

If the answer is unclear in any one of these areas, the system likely needs work.

Summary

21 CFR Part 111 compliance is not about having a few SOPs on file. It is about running a controlled dietary supplement operation with qualified people, written procedures, defined specifications, active quality control, reliable records, and packaging and labeling systems that hold up under review.

The best way to approach Part 111 is not to treat it as a one-time audit hurdle. Treat it as an operating framework. That makes compliance more sustainable and makes third-party verification more valuable.